Related Experiment Video
Updated: May 4, 2026
09:37
Invasive Hemodynamic Characterization of the Portal-hypertensive Syndrome in Cirrhotic Rats
Published on: August 1, 2018
14.4K
Renal and hepatobiliary dysfunction in chronic obstructive pulmonary disease.
1Lovelace Clinic Foundation, Health Services Research Division, Albuquerque, New Mexico, USA.
Current Opinion in Pulmonary Medicine
|December 28, 2013
Summary
Chronic obstructive pulmonary disease (COPD) is linked to kidney and liver diseases. Understanding these connections is crucial for managing patient outcomes and exploring underlying causes.
Area of Science:
- Pulmonary Medicine
- Nephrology
- Hepatology
Background:
- Chronic obstructive pulmonary disease (COPD) affects multiple organ systems beyond the lungs.
- Emerging evidence suggests significant associations between COPD and both renal and hepatobiliary diseases.
Purpose of the Study:
- To review the epidemiology and clinical outcomes of renal and hepatobiliary diseases in COPD patients.
- To explore current knowledge on pathophysiologic mechanisms and risk factors linking COPD with these conditions.
Main Methods:
- Literature review of observational studies and clinical data.
- Analysis of epidemiological surveys and population-based data.
- Synthesis of current understanding of pathophysiologic mechanisms.
Main Results:
- COPD is associated with abnormal kidney function, including impaired glomerular filtration and waste excretion, exacerbated by hypoxemia and hypercarbia.
- Hypoxia, decreased arterial compliance, and renal glomerular injury are implicated in the progression of chronic kidney disease in COPD.
- COPD patients exhibit an elevated risk for specific hepatobiliary diseases and asymptomatic elevations in hepatic transaminases.
Conclusions:
- Renal complications are common in COPD, particularly in patients with hypoxemia and hypercarbia.
- Pathophysiological roles of renal-endocrine mechanisms, tissue hypoxia, and vascular rigidity are recognized but causal relationships require further elucidation.
- Increased risk for hepatobiliary diseases in COPD warrants attention, though prevalence of asymptomatic transaminase elevations is relatively low.
More Related Videos
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
4.0K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K